HSF1 and cancer: As the primary factor in molecular chaperone expression, HSF1 activation is a proteostatic strategy for several aging diseases, and further insights into the mechanism of HSF1 activation would provide important advances for endeavors to therapeutically modulate its activity in both cancer, neurodegeneration, and aging [203].